J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 8,660.00
+820.00 (10.46%)
At close: Jul 21, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 50.64 billion as of July 21, 2026. Its market cap has decreased by -21.49% in one year.
Market Cap
50.64B
Enterprise Value
42.37B
Revenue
36.82B
Ranking
n/a
PE Ratio
12.53
Stock Price
8,660.00
ChartMarket Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 50.64B, a decrease of -65.06%. That is a compound annual growth rate of -36.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 50.64B | 0.70% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 62.10B |
| KoBioLabs | 60.98B |
| ABION | 59.11B |
| Aptamer Sciences | 57.99B |
| Naturalendo Tech | 57.15B |
| IMGT Co.,Ltd. | 56.71B |
| Psomagen | 51.07B |
| TegoScience | 49.24B |